Recent news and posts
Summary of the HTA, funding and innovation payment landscape for peripheral vascular technologies in Europe
MTRC has developed three reports on the key market access topics, including innovation funding, health technology assessment and funding frameworks for medical devices. These reports help to understand the relevance of these frameworks to certain types of medical technologies, including peripheral vascular technologies.
Did you know that:
- There were 9 health technology assessments of peripheral vascular technologies in 2018 in Europe;
- These assessments were published only in 2 EU countries;
- Only 2 assessment were published by the regional HTA bodies, the remaining were published by the national organizations;
- There were 30 funding decisions about peripheral vascular technologies published in 4 EU with established funding frameworks countries for all time periods;
- In 50% of the cases, funding decisions were positive in relation to peripheral vascular technologies;
- There were 7 positive innovation funding decisions (NUB) for peripheral vascular in Germany in 2019.
By accessing one or several of our syndicated reports you can:
- Understand the relevance of topics of innovation funding, health technology assessment and funding frameworks in the peripheral vascular field;
- Understand, which countries are more active with HTA, funding and innovation funding for peripheral vascular devices;
- Understand, what types of technologies typically triggers HTA or review by the funding authorities / decision-makers;
- Understand, what peripheral vascular technologies got positive and negative funding decisions;
- Develop fact-based market access strategies for your portfolio of devices;
- Prioritize markets, based on the solid information about HTA and reimbursement activity for your type of product.
You can get access either to the full reports or limited to the topic of peripheral vascular devices. Download sample pages of the reports via the links provided above.
Contact us at firstname.lastname@example.org to request a quote or get more information.